BATS BZX Real-Time Price
As of 11:44am ET
| -0.05 / -1.08%|
The 3 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +118.34% increase from the last price of 4.58.
The current consensus among 4 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.